Use of Tracking Devices to Locate Abnormalities During Invasive Procedures | MicrobiomeTrials← Back to trialsNCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2005-02-23Est. Completion: 2028-08-02
Enrollment target: 3,894 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Intrahepatic Cholangiocarcinoma (Icc)
This is a phase III, multicenter, open-label, randomized controlled trial designed to evaluate the efficacy and safety o…
Guangzhou, ChinaEst. completion Jan 2030
Lung Cancer
This study aims to evaluate whether femtosecond laser imaging combined with FastLung AI model can provide intraoperative…
Shanghai, ChinaEst. completion Oct 30, 2026
Phase 1
Recruiting
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United StatesEst. completion Dec 31, 2029